These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9652329)

  • 1. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus.
    Hahn MK; Bannon MJ
    Eur J Pharmacol; 1998 May; 348(2-3):155-60. PubMed ID: 9652329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation.
    Hahn MK; Bannon MJ
    Neuroscience; 1999; 94(4):1183-8. PubMed ID: 10625057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
    Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
    Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the effects of tachykinin NK1 receptor antagonists: neuronal versus smooth muscle tissues.
    Seabrook GR; Main MJ; Razzaque Z; Longmore J
    Eur J Pharmacol; 1993 Nov; 250(1):125-31. PubMed ID: 7509748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RP67580, a neurokinin1 receptor antagonist, decreased restraint stress-induced defecation in rat.
    Ikeda K; Miyata K; Orita A; Kubota H; Yamada T; Tomioka K
    Neurosci Lett; 1995 Sep; 198(2):103-6. PubMed ID: 8592631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
    Culman J; Klee S; Ohlendorf C; Unger T
    J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist.
    Hutson PH; Patel S; Jay MT; Barton CL
    Eur J Pharmacol; 2004 Jan; 484(1):57-64. PubMed ID: 14729382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromodacryorrhea and repetitive hind paw tapping: models of peripheral and central tachykinin NK1 receptor activation in gerbils.
    Bristow LJ; Young L
    Eur J Pharmacol; 1994 Mar; 253(3):245-52. PubMed ID: 7515350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats.
    Courteix C; Lavarenne J; Eschalier A
    Eur J Pharmacol; 1993 Sep; 241(2-3):267-70. PubMed ID: 7694865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions.
    Haddjeri N; Blier P
    Eur J Pharmacol; 2008 Dec; 600(1-3):64-70. PubMed ID: 18930727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachykinin effects on bladder activity in conscious normal rats.
    Ishizuka O; Mattiasson A; Andersson KE
    J Urol; 1995 Jul; 154(1):257-61. PubMed ID: 7539864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.
    Cellier E; Barbot L; Iyengar S; Couture R
    Br J Pharmacol; 1999 Jun; 127(3):717-28. PubMed ID: 10401563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider.
    Palframan RT; Costa SK; Wilsoncroft P; Antunes E; de Nucci G; Brain SD
    Br J Pharmacol; 1996 May; 118(2):295-8. PubMed ID: 8735630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin1A receptor agonists induce Fos protein expression in the locus coeruleus of the conscious rat.
    Hamamura T; Lee Y; Fujiwara Y; Kuroda S
    Brain Res; 1997 Jun; 759(1):156-9. PubMed ID: 9219875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for tachykinin NK1 receptor-mediated neutrophil accumulation in the rat cutaneous microvasculature by thermal injury.
    Pintér E; Brown B; Hoult JR; Brain SD
    Eur J Pharmacol; 1999 Mar; 369(1):91-8. PubMed ID: 10204686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil.
    Smith G; Harrison S; Bowers J; Wiseman J; Birch P
    Eur J Pharmacol; 1994 Dec; 271(2-3):481-7. PubMed ID: 7705448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.